Published in Blood Weekly, June 19th, 2003
PolyHeme is the company's universally compatible oxygen-carrying blood substitute intended for use in the treatment of hemorrhagic shock resulting from extensive blood loss.
The trial is designed to assess the safety and efficacy of PolyHeme in improving survival when used to treat severely injured and bleeding trauma patients beginning at the scene of injury and continuing during...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.